BioCentury
ARTICLE | Strategy

Novartis ins and outs

February 1, 2010 8:00 AM UTC

During Daniel Vasella's 14-year tenure as CEO of Novartis AG (NYSE:NVS; SIX:NOVN), the company made a concerted effort to add healthcare assets, while jettisoning non-healthcare businesses. In 1996, w...